Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa
Clinical trial NCT06079372 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06079372
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2025-07-23
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.